Pharmaceutical Gelatin Market Analysis

Pharmaceutical Gelatin Market Analysis

To get key market trends

  Download Free Sample

Based on type, the pharmaceutical gelatin market is segmented as type A and type B. The Type B category dominated the market with a business share of 65.4% in the year 2022. The dominance is due to a variety of factors including cost-effective production due to the availability of raw materials and its use in a variety of applications across the pharmaceutical industry. Also, type B gelatin provide increased gel storage stability than low-bloom gelatin that enables industry players to opt for such product type, thereby augmenting the segment landscape.
 

Based on source, the pharmaceutical gelatin market is segmented into porcine, bovine, fish, and poultry. Porcine source dominated the market with revenue of 520.5 million in 2022. The quick manufacturing cycle, cost-effective production and utilization of porcine based products in pharmaceutical industry are few significant aspects for driving the segment share. For instance, according to the National Health Service (NHS), the use of porcine-based products as a stabiliser in various vaccines and capsules to maintain efficacy and safety, particularly during and after storage.
 

Based on function, Based on function, the pharmaceutical gelatin market is segmented into stabilizers, thickeners, gelling agents, film forming, adhesion and other functions. The stabilizers segment is expected to show considerable growth of 7.4% during the analysis period. The rising use of gelatin as a vaccine stabilizer is projected to fuel segment outlook. Few vaccines contain a stabilizer made from well processed gelatin with minimal endotoxin levels that help in lowering the risk of side effects and assuring patient safety. It also aids in the stability of lyophilized (freeze-dried) products.
 

Based on application, the pharmaceutical gelatin market is segmented into capsules, tablets, absorbable haemostats & other applications. Further, the capsules segment are sub-divided into hard and soft capsules. The capsules segment dominated the market in 2022 and is estimated to reach 970.6 million by 2032. The gelatin softgel capsule offer several advantages such as ease of swallowing, longer shelf life and taste masking will propel the segment development. Moreover, high preference of pharmaceutical manufacturer for gelatin based empty capsules for different formulations due to non-reactive nature and ease of use is anticipated to supplement the capsule market share.
 

North America pharmaceutical gelatin market is anticipated to witness a 41.2% market share in 2022. Presence of key market participants along with developed healthcare infrastructure are among the factors responsible for North America's prominent position in the pharmaceutical gelatin industry. Also, rising gelatin capsule manufacturing services in North America is one of the major factor for market expansion. For instance, in March 2021. CapsCanada, a capsule technology company, announced a new service for the creation of liquid-filled hard capsules. The new service is aimed to support the entire manufacturing process, from product discovery and formulation to full-scale production. Such activities are projected to expand the use of pharmaceutical gelatin for capsule filling in formulation development.